199 related articles for article (PubMed ID: 20608809)
1. Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome.
Amato MC; Verghi M; Nucera M; Galluzzo A; Giordano C
Gynecol Endocrinol; 2011 Aug; 27(8):579-86. PubMed ID: 20608809
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls.
Cho LW; Kilpatrick ES; Keevil BG; Jayagopal V; Coady AM; Rigby AS; Atkin SL
Horm Metab Res; 2011 Feb; 43(2):141-5. PubMed ID: 21234853
[TBL] [Abstract][Full Text] [Related]
5. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
[TBL] [Abstract][Full Text] [Related]
6. Is hyperandrogenemia protective for fibrocystic breast disease in PCOS?
Ozkaya E; Cakir E; Cinar M; Kara F; Baser E; Cakir C; Kucukozkan T
Gynecol Endocrinol; 2012 Jun; 28(6):468-71. PubMed ID: 22103710
[TBL] [Abstract][Full Text] [Related]
7. Irregular cycles and steroid hormones in polycystic ovary syndrome.
Doi SA; Al-Zaid M; Towers PA; Scott CJ; Al-Shoumer KA
Hum Reprod; 2005 Sep; 20(9):2402-8. PubMed ID: 15932911
[TBL] [Abstract][Full Text] [Related]
8. Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women.
Maitra A; Pingle RR; Menon PS; Naik V; Gokral JS; Meherji PK
Int J Fertil Womens Med; 2001; 46(5):271-7. PubMed ID: 11720200
[TBL] [Abstract][Full Text] [Related]
9. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
10. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Yilmaz M; Isaoglu U; Delibas IB; Kadanali S
J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
12. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
13. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).
Giallauria F; Palomba S; Maresca L; Vuolo L; Tafuri D; Lombardi G; Colao A; Vigorito C; Francesco O
Clin Endocrinol (Oxf); 2008 Nov; 69(5):792-8. PubMed ID: 18505468
[TBL] [Abstract][Full Text] [Related]
14. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.
Carmina E; Orio F; Palomba S; Longo RA; Lombardi G; Lobo RA
Fertil Steril; 2005 Aug; 84(2):413-9. PubMed ID: 16084883
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
16. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.
Androulakis II; Kandaraki E; Christakou C; Karachalios A; Marinakis E; Paterakis T; Diamanti-Kandarakis E
Clin Endocrinol (Oxf); 2014 Sep; 81(3):426-31. PubMed ID: 24601936
[TBL] [Abstract][Full Text] [Related]
17. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
Takeuchi T; Tsutsumi O; Taketani Y
Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
[TBL] [Abstract][Full Text] [Related]
18. Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome.
Liang SJ; Liou TH; Lin HW; Hsu CS; Tzeng CR; Hsu MI
Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1167-72. PubMed ID: 22497305
[TBL] [Abstract][Full Text] [Related]
19. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
[TBL] [Abstract][Full Text] [Related]
20. Estradiol-to-testosterone ratio is associated with response to metformin treatment in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS).
Horng SG; Wang TH; Wang HS
Chang Gung Med J; 2008; 31(5):477-83. PubMed ID: 19097595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
